Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott N Gettinger

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Drugs|January 30, 2010
Management of patients with advanced non-small cell lung cancer: current and emerging optionsLaura R Triano, Hari Deshpande, Scott N Gettinger
Current Opinion in Oncology|November 29, 2007
Novel chemotherapy options for advanced thyroid tumors: small molecules offer great hopeHari A Deshpande, Scott N Gettinger, Julie Ann Sosa
Current Opinion in Investigational Drugs (London, England : 2000)|May 25, 2010
Targeted therapy for thyroid cancer: An updated review of investigational agentsHari A Deshpande, Scott N Gettinger, Julie A Sosa
JAAD Case Reports|August 17, 2018
Pityriasis rubra pilaris-like erythroderma in the setting of pembrolizumab therapy responsive to acitretinEmily Coleman, Gauri Panse, Jason Haldas, et al.
Journal of Thoracic Disease|April 16, 2013
Late recurrence of basaloid carcinoma initially treated as a small cell lung cancerVladimir Shumaster, Jason W Bae, Scott N Gettinger, et al.
Oncoimmunology|September 28, 2013
SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancerKavita M Dhodapkar, Scott N Gettinger, Rituparna Das, et al.
Journal for Immunotherapy of Cancer|October 18, 2017
Immuno-thermal ablations - boosting the anticancer immune responseRyan Slovak, Johannes M Ludwig, Scott N Gettinger, et al.
Journal for Immunotherapy of Cancer|December 6, 2018
Oncolytic virus immunotherapy: future prospects for oncologyJunaid Raja, Johannes M Ludwig, Scott N Gettinger, et al.
Journal of Thrombosis and Thrombolysis|March 25, 2021
Clinical characteristics and outcomes of splenic infarction in cancer patients: a retrospective, single center report of 206 casesJan Philipp Bewersdorf, Nishita Parmar, Gary M Israel, et al.
Journal for Immunotherapy of Cancer|December 14, 2018
Cryotherapy for nodal metastasis in NSCLC with acquired resistance to immunotherapyLucas C Adam, Junaid Raja, Johannes M Ludwig, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Drugs|January 30, 2010
Management of patients with advanced non-small cell lung cancer: current and emerging optionsLaura R Triano, Hari Deshpande, Scott N Gettinger
Current Opinion in Oncology|November 29, 2007
Novel chemotherapy options for advanced thyroid tumors: small molecules offer great hopeHari A Deshpande, Scott N Gettinger, Julie Ann Sosa
Current Opinion in Investigational Drugs (London, England : 2000)|May 25, 2010
Targeted therapy for thyroid cancer: An updated review of investigational agentsHari A Deshpande, Scott N Gettinger, Julie A Sosa
JAAD Case Reports|August 17, 2018
Pityriasis rubra pilaris-like erythroderma in the setting of pembrolizumab therapy responsive to acitretinEmily Coleman, Gauri Panse, Jason Haldas, et al.
Journal of Thoracic Disease|April 16, 2013
Late recurrence of basaloid carcinoma initially treated as a small cell lung cancerVladimir Shumaster, Jason W Bae, Scott N Gettinger, et al.
Oncoimmunology|September 28, 2013
SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancerKavita M Dhodapkar, Scott N Gettinger, Rituparna Das, et al.
Journal for Immunotherapy of Cancer|October 18, 2017
Immuno-thermal ablations - boosting the anticancer immune responseRyan Slovak, Johannes M Ludwig, Scott N Gettinger, et al.
Journal for Immunotherapy of Cancer|December 6, 2018
Oncolytic virus immunotherapy: future prospects for oncologyJunaid Raja, Johannes M Ludwig, Scott N Gettinger, et al.
Journal of Thrombosis and Thrombolysis|March 25, 2021
Clinical characteristics and outcomes of splenic infarction in cancer patients: a retrospective, single center report of 206 casesJan Philipp Bewersdorf, Nishita Parmar, Gary M Israel, et al.
Journal for Immunotherapy of Cancer|December 14, 2018
Cryotherapy for nodal metastasis in NSCLC with acquired resistance to immunotherapyLucas C Adam, Junaid Raja, Johannes M Ludwig, et al.
Pageof 7